SCHEMBL5707278

SCHEMBL5707278

CC(C)[C@H](C(N)=O)N(C(=O)OCC1c2ccccc2-c2ccccc21)C(=O)C(N)Cc1cccc2ccccc12

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.36
▸ NLN Q9BYT8 2/20 0.35
▸ MMP9 P14780 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ METAP2 P50579 5/20 0.33
▸ METAP1 P53582 3/20 0.33
▸ TACR1 P25103 1/20 0.33
▸ EPHX2 P34913 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ CTNNB1 P35222 1/20 0.32
▸ CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5035599 0.78 KMT2A (0.40) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL119785 0.73 CTNNB1 (0.39) KMT2AMMP9MEN1ALDH1A1MAPT
SCHEMBL16108213 0.73 CTNNB1 (0.39) KMT2AMMP9MEN1ALDH1A1MAPT
SCHEMBL119780 0.73 CTNNB1 (0.39) KMT2AMMP9MEN1ALDH1A1MAPT
SCHEMBL29981793 0.73 CTNNB1 (0.39) KMT2AMMP9MEN1ALDH1A1MAPT
SCHEMBL13978398 0.72 MDM4 (0.47) KMT2AEPHX2CASP3
SCHEMBL30683550 0.71 KMT2A (0.46) KMT2AEPHX2CASP3
SCHEMBL2922997 0.71 SLC1A3 (0.42) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL119531 0.70 FABP5 (0.48) KMT2AEPHX2CASP3
SCHEMBL31520504 0.69 KMT2A (0.44) KMT2AALDH1A1EPHX2L3MBTL1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1692099-A1 SOMATOSTATINE RECEPTOR SUBTYPE 1 (SSTR1) ACTIVE COMPOUNDS AND THEIR USE IN THERAPY Oy Juvantia Pharma Ltd (FI) 2006-08-23 — — EP disclosed
WO-2005056520-A1 SOMATOSTATIN RECEPTOR SUBTYPE 1 (SSTR1) ACTIVE COMPOUNDS AND THEIR USE IN THERAPY OY JUVANTIA PHARMA LTD (FI) 2005-06-23 — — WO disclosed
Send feedback